Millions of Americans are not taking their GLP-1 drugs as prescribed
Cost and access barriers are pushing people to modified use and unapproved versions.
Cost and access barriers are pushing people to modified use and unapproved versions. This story matters for AI & Agent Economy readers tracking app. Reported by arstechnica.com. Read the full original at the source link below.
Originally reported by arstechnica.com. AppNewsletter.com curates and briefs the ai & agent economy stories that matter. Our editorial policy →
Get the daily app signal